Value of lifestyle intervention to prevent diabetes and sequelae

American Journal of Preventive Medicine

Volumn 48, Issue 3, 2015, Pages 271-280

  Dall, Timothy M ^a   Storm, Michael V ^a   Semilla, April P ^a   Wintfeld, Neil ^c   O'Grady, Michael ^b   Venkat Narayan, K M ^d  

^a FEKETE ASSOCIATES INC   (United States)

^b UNIVERSITY OF CHICAGO   (United States)

^c NOVO NORDISK INC   (United States)

^d EMORY UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AMPUTATION; ARTICLE; BLINDNESS; CEREBROVASCULAR ACCIDENT; CONGESTIVE HEART FAILURE; COST BENEFIT ANALYSIS; COST CONTROL; FEMALE; FOLLOW UP; HEALTH CARE COST; HEALTH SURVEY; HEART INFARCTION; HUMAN; IMPAIRED GLUCOSE TOLERANCE; ISCHEMIC HEART DISEASE; KIDNEY FAILURE; LIFESTYLE MODIFICATION; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MORTALITY; NON INSULIN DEPENDENT DIABETES MELLITUS; OUTCOME ASSESSMENT; POPULATION; PREVENTIVE MEDICINE; QUALITY ADJUSTED LIFE YEAR; QUALITY OF LIFE; SCREENING; SIMULATION; BLOOD; BLOOD PRESSURE; BODY MASS; COMORBIDITY; COMPLICATION; DIABETES MELLITUS, TYPE 2; DIET; EXERCISE; HEALTH BEHAVIOR; LIFESTYLE; MASS SCREENING; NUTRITION; PREDIABETIC STATE; PROBABILITY; RISK FACTOR;

CHOLESTEROL; GLYCOSYLATED HEMOGLOBIN;

BLOOD PRESSURE; BODY MASS INDEX; CHOLESTEROL; COMORBIDITY; DIABETES MELLITUS, TYPE 2; DIET; EXERCISE; FEMALE; HEALTH BEHAVIOR; HEALTH EXPENDITURES; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; LIFE STYLE; MALE; MARKOV CHAINS; MASS SCREENING; MIDDLE AGED; NUTRITION SURVEYS; PREDIABETIC STATE; QUALITY OF LIFE; RISK FACTORS;

EID: 84926182645     PISSN: 07493797     EISSN: 18732607     Source Type: Journal    
DOI: 10.1016/j.amepre.2014.10.003     Document Type: Article

References (66)

1. CDC. National diabetes fact sheet. 2011. http://www.cdc.gov/diabetes/pubs/pdf/ndfs-2011.pdf
2. G.A. Nichols, T.A. Hillier, and J.B. Brown Progression from newly acquired impaired fasting glusose to type 2 diabetes Diabetes Care 30 2 2007 228 233
3. C.L. Gillies, P.C. Lambert, and K.R. Abrams Different strategies for screening and prevention of type 2 diabetes in adults: cost effectiveness analysis BMJ 336 7654 2008 1180 1185
4. S.S. Rasmussen, C. Glumer, A. Sandbaek, T. Lauritzen, and K. Borch-Johnsen Progression from impaired fasting glucose and impaired glucose tolerance to diabetes in a high-risk screening programme in general practice: the ADDITION Study, Denmark Diabetologia 50 2 2007 293 297
5. S.S. Rasmussen, C. Glumer, A. Sandbaek, T. Lauritzen, and K. Borch-Johnsen Determinants of progression from impaired fasting glucose and impaired glucose tolerance to diabetes in a high-risk screened population: 3 year follow-up in the ADDITION study, Denmark Diabetologia 51 2 2008 249 257
6. Diabetes Prevention Program Research Group Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin N Engl J Med 346 6 2002 393 403
7. W.C. Knowler, S.E. Fowler, and R.F. Hamman 10-year follow-up of diabetes incidence and weight loss in the Diabetes Prevention Program Outcomes Study Lancet 374 9702 2009 1677 1686
8. C.L. Gillies, K.R. Abrams, and P.C. Lambert Pharmacological and lifestyle interventions to prevent or delay type 2 diabetes in people with impaired glucose tolerance: systematic review and meta-analysis BMJ 334 7588 2007 299
9. A.L. Albright, and E.W. Gregg Preventing type 2 diabetes in communities across the U.S.: the National Diabetes Prevention Program Am J Prev Med 44 4S4 2013 S346 S351
10. American Diabetes Association Standards of medical care in diabetes-2014 Diabetes Care 37 S14 2014 S14 S80 http://care.diabetesjournals.org/content/37/Supplement-1/S14.extract
11. U.S. Preventive Services Task Force. Screening for Type 2 Diabetes Mellitus in Adults, Topic Page. August 1, 2013. http://www.uspreventiveservicestaskforce.org/Page/Document/ClinicalSummaryFinal/diabetes-mellitus-type-2-in-adults-screening.
12. T.M. Dall, Y. Zhang, and S. Zhang Weight loss and lifetime medical expenditures: a case study with TRICARE prime beneficiaries Am J Prev Med 40 3 2011 338 344
13. W. Yang, T.M. Dall, and Y. Zhang Simulation of quitting smoking in the military shows higher lifetime medical spending more than offset by productivity gains Health Aff (Millwood) 31 12 2012 2717 2726
14. Diabetes Prevention Program Research Group The 10-year cost-effectiveness of lifestyle intervention or metformin for diabetes prevention: an intent-to-treat analysis of the DPP/DPPOS Diabetes Care 35 4 2012 723 730
15. J.J. Caro, A.H. Briggs, U. Siebert, and K.M. Kuntz Modeling good research practices - overview: a report of the ISPOR-SMDM Modeling Good Research Practices Task Force - 1 Value Health 15 6 2012 796 803
16. National Center for Health Statistics. Continous NHANES Web Tutorial. 2013. http://www.cdc.gov/nchs/tutorials/NHANES/index-continuous.htm.
17. K.M. Newton, E.H. Wagner, and S.D. Ramsey The use of automated data to identify complications and comorbidities of diabetes: a validation study J Clin Epidemiol 52 3 1999 199 207
18. CDC National diabetes statistics report, 2014 2014 CDC Atlanta GA
19. P.M. Clarke, A.M. Gray, and A. Briggs A model to estimate the lifetime health outcomes of patients with type 2 diabetes: the United Kingdom Prospective Diabetes Study (UKPDS) Outcomes Model (UKPDS no. 68) Diabetologia 47 10 2004 1747 1759
20. W.B. Kannel, P.A. Wolf, E.J. Benjamin, and D. Levy Prevalence, incidence, prognosis, and predisposing conditions for atrial fibrillation: population-based estimates Am J Cardiol 82 7 1998 2 9N
21. G.A. Nichols, K. Reinier, and S.S. Chugh Independent contribution of diabetes to increased prevalence and incidence of atrial fibrillation Diabetes Care 32 10 2009 1851 1856
22. K.M. Anderson, P.M. Odell, P.W. Wilson, and W.B. Kannel Cardiovascular disease risk profiles Am Heart J 121 1 1991 293 298
23. J. Hippisley-Cox, and C. Coupland Predicting the risk of chronic kidney disease in men and women in England and Wales: prospective derivation and external validation of the QKidney-Scores BMC Fam Pract 11 1 2010 49
24. P.W. Wilson, K.M. Anderson, T. Harri, W.B. Kannel, and W.P. Castelli Determinants of change in total cholesterol and HDL-C with age: the Framingham Study J Gerontol 49 6 1994 M252 M257
25. P.W. Wilson, S.R. Bozeman, and T.M. Burton Prediction of first events of coronary heart disease and stroke with consideration of adiposity Circulation 118 2 2008 124 130
26. K.K. Ho, K.M. Anderson, W.B. Kannel, W. Grossman, and D. Levy Survival after the onset of congestive heart failure in Framingham Heart Study subjects Circulation 88 1 1993 107 115
27. USDHHS The Framingham Study: an epidemiological intervention of cardiovascular diseases: section 34: some risk factors related to the annual incidence of cardiovascular disease and death using pooled repeated biennial measurements: Framingham Heart Study, 30 year followup April 13, 2009 USDHHS Washington DC
28. R.B. D'Agostino, R.S. Vasan, and M.J. Pencina General cardiovascular risk profile for use in primary care the Framingham Heart Study Circulation 117 6 2008 743 753
29. T.J. Sheehan, S. DuBrava, L.M. DeChello, and Z. Fang Rates of weight change for black and white Americans over a twenty year period Int J Obesity 27 4 2003 498 504
30. J.E. Neter, B.E. Stam, F.J. Kok, D.E. Grobbee, and J.M. Geleijnse Influence of weight reduction on blood pressure a meta-analysis of randomized controlled trials Hypertension 42 5 2003 878 884
31. Y. Heianza, Y. Arase, and K. Fujihara Longitudinal trajectories of HbA1c and fasting plasma glucose levels during the development of type 2 diabetes the Toranomon Hospital Health Management Center Study 7 (TOPICS 7) Diabetes Care 35 5 2012 1050 1052
32. American Diabetes Association Diagnosis and classification of diabetes mellitus Diabetes Care 33 S1 2010 S62 S69
33. National Heart, Lung, and Blood Institute Obesity initiative: the practical guide: identification, evaluation, and treatment of overweight and obesity in adults October 1, 2000 National Heart, Lung, and Blood Institute Washington DC
34. G. de Simone, R.B. Devereux, M.J. Roman, M.H. Alderman, and J.H. Laragh Relation of obesity and gender to left ventricular hypertrophy in normotensive and hypertensive adults Hypertension 23 5 1994 600 606
35. J.D. Hooi, A.D. Kester, and H.E. Stoffers Incidence of and risk factors for asymptomatic peripheral arterial occlusive disease: a longitudinal study Am J Epidemiol 153 7 2001 666 672
36. M. Schaufelberger, K. Swedberg, M. Koster, M. Rosen, and A. Rosengren Decreasing one-year mortality and hospitalization rates for heart failure in Sweden Data from the Swedish Hospital Discharge Registry 1988 to 2000 Eur Heart J 25 4 2004 300 307
37. Socialstyrelsen Swedish Health and Welfare Statistical Databases: AMI statistics Socialstyrelsen 2013 http://www.socialstyrelsen.se/statistics
38. K.N. Vemmos, M.L. Bots, and P.K. Tsibouris Prognosis of stroke in the south of Greece: 1 year mortality, functional outcome and its determinants: the Arcadia Stroke Registry J Neurol Neurosurg Psychiatry 69 5 2000 595 600
39. M. Tonelli, N. Wiebe, and B. Culleton Chronic kidney disease and mortality risk: a systematic review J Am Soc Nephrol 17 7 2006 2034 2047
40. CDC, National Center for Health Statistics. Underlying cause of death 1999-2010 on CDC WONDER Online Database. Released 2012. http://wonder.cdc.gov.
41. P. Zhang, M.B. Brown, and D. Bilik Health utility scores for people with type 2 diabetes in U.S. managed care health plans results from Translating Research Into Action for Diabetes (TRIAD) Diabetes Care 35 11 2012 2250 2256
42. P.W. Sullivan, W.F. Lawrence, and V. Ghushchyan A national catalog of preference-based scores for chronic conditions in the United States Med Care 43 7 2005 736 749
43. G.F. Riley, and J.D. Lubitz Long-term trends in Medicare payments in the last year of life Health Serv Res 45 2 2010 565 576
44. T.M. Dall, K.M. Narayan, and K.B. Gillespie Detecting type 2 diabetes and prediabetes among asymptomatic adults in the United States: modeling American Diabetes Association versus US Preventive Services Task Force diabetes screening guidelines Popul Health Metr 12 2014 12
45. D. Vojta, T.B. Koehler, M. Longjohn, J.A. Lever, and N.F. Caputo A coordinated national model for diabetes prevention: linking health systems to an evidence-based community program Am J Prev Med 44 4S4 2013 S301 S306
46. M.S. Lawlor, C.S. Blackwell, and S.P. Isom Cost of a group translation of the Diabetes Prevention Program: healthy living partnerships to prevent diabetes Am J Prev Med 44 4S4 2013 S381 S389
47. W.H. Hernan, M. Brandle, and P. Zhang Costs associated with the primary prevention of type 2 diabetes mellitus in the diabetes prevention program Diabetes Care 26 1 2003 36 47
48. E. Alibasic, E. Ramic, and A. Alic Prevention of diabetes in family medicine Mater Sociomed 25 2 2013 80 82
49. J. Tuomilehto, P. Schwarz, and J. Lindstrom Long-term benefits from lifestyle interventions for type 2 diabetes prevention: time to expand the efforts Diabetes Care 34 S2 2011 S210 S214
50. P. Zhang, M.M. Engelgau, and R. Valdez Costs of screening for pre-diabetes among US adults: a comparison of different screening strategies Diabetes Care 26 9 2003 2536 2542
51. S.L. Norris, D. Kansagara, C. Bougatsos, and R. Fu Screening adults for type 2 diabetes: a review of the evidence for the US Preventive Services Task Force Ann Intern Med 148 11 2008 855 868
52. R. English, Y. Lebovitz, and R. Griffin Transforming clinical research in the United States: challenges and opportunities: workshop summary 2010 The National Academies Press Washington DC
53. R. Kahn, P. Alperin, and D. Eddy Age at initiation and frequency of screening to detect type 2 diabetes: a cost-effectiveness analysis Lancet 375 9723 2010 1365 1374
54. A.J. Palmer, P. Clarke, and A. Gray Computer modeling of diabetes and its complications: a report on the Fifth Mount Hood challenge meeting Value Health 16 4 2013 670 685
55. R.J. Stevens, V. Kothari, A.I. Adler, I.M. Stratton, and R.R. Holman The UKPDS risk engine: a model for the risk of coronary heart disease in Type II diabetes (UKPDS 56) Clin Sci (Lond) 101 6 2001 671 679
56. T.J. Hoerger, J.E. Segel, P. Zhang, and S.W. Sorensen Validation of the CDC-RTI diabetes cost-effectiveness model. RTI Press Publication No. MR-0013-090 2009 RTI International Research Triangle Park NC
57. A.J. Palmer, S.p. Roze, and W.J. Valentine The CORE Diabetes Model: projecting long-term clinical outcomes, costs and costeffectiveness of interventions in diabetes mellitus (types 1 and 2) to support clinical and reimbursement decision-making Curr Med Res Opin 20 S1 2004 S5 S26
58. J.S. Yudkin, and V.M. Montori The epidemic of pre-diabetes: the medicine and the politics BMJ 349 2014 g4485
59. R.R. Wing, P. Bolin, and F.L. Brancati Cardiovascular effects of intensive lifestyle intervention in type 2 diabetes N Engl J Med 369 2 2013 145 154
60. R.R. Wing Long-term effects of a lifestyle intervention on weight and cardiovascular risk factors in individuals with type 2 diabetes mellitus: four-year results of the Look AHEAD trial Arch Intern Med 170 17 2010 1566 1575
61. E.S. Nylen, C. Faselis, and R. Kheirbek Statins modulate the mortality risk associated with obesity and cardiorespiratory fitness in diabetics J Clin Endocrinol Metab 98 8 2013 3394 3401
62. C. James, K.M. Bullard, and D.B. Rolka Implications of alternative definitions of prediabetes for prevalence in U.S. adults Diabetes Care 34 2 2011 387 391
63. D.P. Guh, W. Zhang, and N. Bansback The incidence of co-morbidities related to obesity and overweight: a systematic review and meta-analysis BMC Public Health 9 1 2009 88
64. H.C. Gerstein, P. Santaguida, and P. Raina Annual incidence and relative risk of diabetes in people with various categories of dysglycemia: a systematic overview and meta-analysis of prospective studies Diabetes Res Clin Pract 78 3 2007 305 312
65. L.S. Geiss, C. James, and E.W. Gregg Diabetes risk reduction behaviors among U.S. adults with prediabetes Am J Prev Med 38 4 2010 403 409
66. K.M. Narayan, J.B. Echouffo-Tcheugui, V. Mohan, and M.K. Ali Analysis & commentary: global prevention and control of type 2 diabetes will require paradigm shifts in policies within and among countries Health Aff (Millwood) 31 1 2012 84 92